Scotiabank analyst Nick Altmann maintained a Hold rating on Confluent (CFLT – Research Report) today and set a price target of $27.00. The ...
TD Cowen analyst Derrick Wood raised the firm’s price target on Confluent (CFLT) to $37 from $31 and keeps a Buy rating on the shares. The firm ...
Confluent Health proudly announces the rebranding of IncreMedical Therapy Solutions to Confluent Health System Solutions. This evolution reflects the commitment to partnering with health systems ...
The Connecticut company’s long-lived logo is now getting a new look tailored for the future and the dramatic shift to digital ...
When the Kansas City Chiefs and Philadelphia Eagles square off on Sunday, it'll mark the fourth straight season in which the ...
Cerebral amyloid angiopathy related inflammation (CAA-RI) is a rare form of CAA characterized by subacute encephalitic symptoms (cognitive decline, seizures, focal deficits) associated with extensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results